Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER

Leukemia, Lymphocytic, Chronic

OHSU Knight Cancer Institutemonoclonal_antibodyPhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Leukemia, Lymphocytic, Chronic cohort.

Asset / SponsorPhaseRating
Equine Atg
Masonic Cancer Center, University of Minnesota
Phase 2B
TRASTUZUMAB
OHSU Knight Cancer Institute
Phase 2B
Epoetin Alfa
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 2B
Denileukin Diftitox
Eisai Inc.
Phase 2CCC
TERIPARATIDE
The Emmes Company, LLC
Phase 2CCC

View all 10 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER is also rated in:

breast carcinomaDormant
BBB
Indicative ·
75 / 100
View asset →
inflammatory breast carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
HER2 positive breast carcinomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →